Evidence map›Paper›PMID 32207832›Full record

ArticleJAMA network open2020

Prevalence of Diabetes Medication Intensifications in Older Adults Discharged From US Veterans Health Administration Hospitals.

Timothy S Anderson, Sei Lee, Bocheng Jing, Kathy Fung, Sarah Ngo, Molly Silvestrini, Michael A Steinman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in JAMA network open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Impact of Hospitalizations on Problematic Medication Use Among Community-Dwelling Persons With Dementia.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  9. Article
  10. Article
  11. Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes.International journal of environmental research and public health · 2023
    Article
  12. Observational
  13. Article
  14. Error in Abstract.JAMA network open · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Timothy S AndersonDivision of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Sei LeeSan Francisco VA Medical Center, San Francisco, California.
Bocheng JingSan Francisco VA Medical Center, San Francisco, California.
Kathy FungSan Francisco VA Medical Center, San Francisco, California.
Sarah NgoSan Francisco VA Medical Center, San Francisco, California.
Molly SilvestriniSan Francisco VA Medical Center, San Francisco, California.
Michael A SteinmanSan Francisco VA Medical Center, San Francisco, California.
San Francisco VA Medical Center · USUniversity of California, San Francisco · USBeth Israel Deaconess Medical Center · US

Funding

VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Keliimoeanu Smith · 2013 to 2026
$19.9M
Unnecessary and Harmful Medication Use in Older Adults with DementiaP01AG066605 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KENNETH E. COVINSKY, R. Sean Morrison · 2020 to 2026
$17.7M
U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BOYD, CYNTHIA MELINDA, STEINMAN, MICHAEL A. · 2019 to 2023
$9.9M
Prescribing cascades in older adults with and without dementiaK24AG049057 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEINMAN, MICHAEL A. · 2015 to 2025
$1.8M
Impact of Intensive Blood Pressure Treatment on Clinical Outcomes of Hospitalized Older AdultsR03AG064373 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ANDERSON, TIMOTHY S · 2019 to 2020
$274k
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention DecisionsI01HX002135 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI LEE, SEI · 2018 to 2021
–
HSRD VA I01 HX002135NIA NIH HHS K24 AG049057NIA NIH HHS L30 AG060493NIA NIH HHS P01 AG066605NIA NIH HHS P30 AG044281NIA NIH HHS R03 AG064373NIA NIH HHS R24 AG064025
6 · The paper itself

Abstract

Importance: Elevated blood glucose levels are common in hospitalized older adults and may lead clinicians to intensify outpatient diabetes medications at discharge, risking potential overtreatment when patients return home. Objective: To assess how often hospitalized older adults are discharged with intensified diabetes medications and the likelihood of benefit associated with these intensifications. Design, Setting, and Participants: This retrospective cohort study examined patients aged 65 years and older with diabetes not previously requiring insulin. The study included patients who were hospitalized in a Veterans Health Administration hospital for common medical conditions between 2011 and 2013. Main Outcomes and Measures: Intensification of outpatient diabetes medications, defined as receiving a new or higher-dose medication at discharge than was being taken prior to hospitalization. Mixed-effect logistic regression models were used to control for patient and hospitalization characteristics. Results: Of 16 178 patients (mean [SD] age, 73 [8] years; 15 895 [98%] men), 8535 (53%) had a preadmission hemoglobin A1c (HbA1c) level less than 7.0%, and 1044 (6%) had an HbA1c level greater than 9.0%. Overall, 1626 patients (10%) were discharged with intensified diabetes medications including 781 (5%) with new insulins and 557 (3%) with intensified sulfonylureas. Nearly half of patients receiving intensifications (49% [791 of 1626]) were classified as being unlikely to benefit owing to limited life expectancy or already being at goal HbA1c, while 20% (329 of 1626) were classified as having potential to benefit. Both preadmission HbA1c level and inpatient blood glucose recordings were associated with discharge with intensified diabetes medications. Among patients with a preadmission HbA1c level less than 7.0%, the predicted probability of receiving an intensification was 4% (95% CI, 3%-4%) for patients without elevated inpatient blood glucose levels and 21% (95% CI, 15%-26%) for patients with severely elevated inpatient blood glucose levels. Conclusions and Relevance: In this study, 1 in 10 older adults with diabetes hospitalized for common medical conditions was discharged with intensified diabetes medications. Nearly half of these individuals were unlikely to benefit owing to limited life expectancy or already being at their HbA1c goal.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsAgedAged, 80 and overBlood GlucoseFemaleGlycated HemoglobinHumansInappropriate PrescribingInsulinMalePatient DischargeRetrospective StudiesSulfonylurea CompoundsVeterans Health ServicesBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinSulfonylurea Compounds

Identifiers

PMID32207832
PMCPMC7093767
OpenAlexW3012766599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.